OncoSec Medical
- Pharmaceutical Preparations
- Pennington, New Jersey
Compensation history
Top executives at OncoSec Medical received an average of $936K per person in annual compensation from 2012 to 2021.
Average pay of disclosed executives at OncoSec Medical
By year
Executives
We found 12 executives who work or worked at OncoSec Medical.
Daniel O'Connor
OncoSec Medical
Chief Executive Officer
Robert DelAversano
OncoSec Medical
Principal Accounting Officer and Controller
Brian Leuthner
OncoSec Medical
Chief Executive Officer
Kellie Foerter
OncoSec Medical
Chief Operating Officer
Sara Bonstein
OncoSec Medical
Chief Financial Officer
Punit Dhillon
OncoSec Medical
Chief Executive Officer
Richard Slansky
OncoSec Medical
Chief Financial Officer
Sharron Gargosky
OncoSec Medical
Chief Clinical and Regulatory Officer
News
OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
May 31, 2022
OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
March 18, 2021
OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
April 30, 2020
OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
November 8, 2018
About OncoSec Medical
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address24 N. Main Street, Pennington, New Jersey 08534
- Phone(858) 210-7333
- Fiscal year endJuly 31
- Former names
- NetVentory Solutions, Inc.Until February 3, 2011
Source: SEC filings on May 31, 2022, March 18, 2021, April 30, 2020, November 8, 2018, November 28, 2017, October 27, 2016, June 17, 2015, and June 6, 2014.